Hepatitis C Support Group
Hepatitis C is a blood-borne viral disease which can cause liver inflammation, fibrosis, cirrhosis and liver cancer. The hepatitis C virus (HCV) is spread by blood-to-blood contact with an infected person's blood. Many people with HCV infection have no symptoms and are unaware of the need to seek treatment. Hepatitis C infects an estimated 150-200 million people worldwide.
"... ION-2 is evaluating sofosbuvir/ledipasvir with RBV for 12 weeks, and with and without RBV for 24 weeks, among 400 treatment-experienced genotype 1 HCV patients..."
Does that mean that the 12 week without riba has been extended to 24 weeks or am I missing something?
treatment experienced not naive, so the mix is a little more aggressive.
I don't see a 12 week no Riba arm like in ION-1 Only arm with no Riba is 24 weeks of sofosbuvir/ledipasvir.
Are we on the same page?
I have more and more cognitive challenges these days.
ION-2 is the next phase for the "hard to treat" population. Hey I might get a call; wouldn't that be cool?? (not holding breath though).